Found 7 matching trials
Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
PHASE2The objective of the study is to evaluate the anti-viral efficacy of 3 diff...
Location
Intensive Care Unit, CHU Gabriel-Montpied
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels
PHASE3The purpose of this study is to assess the safety and efficacy of masitinib...
Location
Centro Respiratorio Quilmes
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
PHASE3The objective is to compare the efficacy and safety of masitinib in combina...
Location
University of Alabama at Birmingham
Masitinib in Refractory Active Rheumatoid Arthritis
PHASE2The objective is to compare efficacy and safety of masitinib at 3 and 6 mg/...
Location
ARTMEDI UPD s.r.o
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
PHASE3The purpose of this study is to evaluate the efficacy and safety of oral ma...
Location
Centre Hospitalier Universitaire d'Amiens
Masitinib for the Treatment of Severe Mast Cell Activation Syndrome
PHASE2To evaluate the efficacy and safety of two dosing schemes of oral masitinib...
Location
St Charles Clinical Research
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
PHASE3Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)...
Location
MD Anderson Cancer Center